These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15365604)

  • 1. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients.
    Vincenti F
    Transpl Int; 2004 Sep; 17(8):395-401. PubMed ID: 15365604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.
    Montagnino G; Sandrini S; Casciani C; Schena FP; Carmellini M; Civati G; Rigotti P; Cossu M; Altieri P; Salvadori M; Federico S; Stefoni S; Cambi V; Albertazzi A; Buoncristiani U; Berloco P; Segoloni G; Boschiero L; Sparacino V; Donati D; Turello E; Dal Canton A; Ponticelli C
    Transplant Proc; 2005 Mar; 37(2):788-90. PubMed ID: 15848532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-sparing strategies.
    Ponticelli C
    Transplant Proc; 2005 Nov; 37(9):3597-9. PubMed ID: 16386481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing early withdrawal or avoidance of steroids with standard steroid therapy in kidney transplant recipients.
    Hricik DE
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):360-1. PubMed ID: 18477989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST).
    Kliem V; Fritsche L; Haller H; Suwelack B; Abendroth D; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U; Ulbricht B;
    Transplant Proc; 2005 Apr; 37(3):1597-600. PubMed ID: 15866683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimization of immunosuppression in kidney transplantation.
    Augustine JJ; Hricik DE
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):535-41. PubMed ID: 18089967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
    Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus: a current perspective.
    Yakupoglu YK; Kahan BD
    Exp Clin Transplant; 2003 Jun; 1(1):8-18. PubMed ID: 15859902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
    Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
    Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of sirolimus to facilitate steroid withdrawal from a cyclosporine regimen.
    Kahan BD; Podbielski J; Schoenberg L
    Transplant Proc; 2006 Nov; 38(9):2842-6. PubMed ID: 17112844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid.
    Citterio F; Sparacino V; Altieri P; Rigotti P; Calabrese S; Poli M; Vinti V; Segoloni GP
    Transplant Proc; 2005 Mar; 37(2):827-9. PubMed ID: 15848545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
    Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
    Clin Transplant; 2008; 22(5):645-50. PubMed ID: 18657156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients.
    Vincenti F; de Andrés A; Becker T; Choukroun G; Cole E; González-Posada JM; Kumar MA; Moore R; Nadalin S; Nashan B; Rostaing L; Saito K; Yoshimura N
    Transpl Int; 2006 Jun; 19(6):446-57. PubMed ID: 16771865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients.
    Dresske B; Haendschke F; Lenz P; Ungefroren H; Jenisch S; Exner B; El Mokhtari NE; Lu T; Zavazava N; Faendrich F
    Transplantation; 2006 Jun; 81(11):1549-57. PubMed ID: 16770244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
    Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
    Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.
    Alloway RR; Hanaway MJ; Trofe J; Boardman R; Rogers CC; Hanaway MJ; Buell JF; Munda R; Alexander JW; Thomas MJ; Roy-Chaudhury P; Cardi M; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):802-3. PubMed ID: 15848537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid minimization in pediatric renal transplantation: Early withdrawal or avoidance?
    Grenda R; Webb NJ
    Pediatr Transplant; 2010 Dec; 14(8):961-7. PubMed ID: 20874824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D
    J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.